Epoch’s biorecycling platform unlocks circularity for the toughest-to-recycle materials. Our AI-designed enzymes enable infinite recycling for mixed plastics and textiles. We operate at commercial scale, producing sustainable products for use in apparel, automotive, packaging and more, starting with nylon 6,6.
| Website | http://www.epochbiodesign.com |
| Revenue | $27.5 million |
| Employees | 83 (62 on RocketReach) |
| Industry | Biotechnology |
| Keywords | Plastic Recycling, Enzyme Technology, Textile Recycling, Biotechnology, Circular Economy, Recycling Solutions, Sustainable Materials, Recycling Innovation, Bio-Based Materials, Material Science, Green Technology, Environmental Sustainability, Sustainable Textiles, Sustainable Apparel, Waste Management, Renewable Resources, Circular Fashion |
| Competitors | CureVac, Moderna Therapeutics, Zymergen, Inc., Amgen, Regeneron, Zymeworks Inc., AstraZeneca, Catalent Pharma Solutions, CRISPR Therapeutics, AbCellera +37 more (view full list) |
Looking for a particular Epoch Biodesign employee's phone or email?
The Epoch Biodesign annual revenue was $27.5 million in 2026.
Jacob Nathan is the Founder and CEO of Epoch Biodesign.
62 people are employed at Epoch Biodesign.
Epoch Biodesign is based in London, England.